Dynamic finance leader with extensive expertise at AstraZeneca, specializing in FP&A and strategic financial analysis.
Overview
19
19
years of professional experience
1
1
Certification
Work History
Senior Global Finance Business Partner
ASTRAZENECA
Gaithersburg, USA
01.2020 - Current
Led FP&A and strategic finance across BioPharma and Oncology Data Science & AI, Neuroscience, and Clinical Pharmacology and Safety Sciences (cost base up to ~$300M; ~1,000 FTEs); owned MTP/QBRs, forecasting, KPI suite, and driver-based operating model.
AI investment stewardship: Consolidated ~$160M AI portfolio (FY26–27; $100M funded/$60M unfunded); built ROI/IRR/NPV; authored capitalization criteria; dashboards for benefit realization % vs. plan, time-to-capitalization, capex utilization, and model-to-decision impact.
Enterprise planning: Delivered QBRs/MTP for ODSAI/DSAI (~$191M, 688 FTEs); tightened driver transparency and RD IT recharge clarity; targeted forecast accuracy ±2%; reduced decision cycle time via standardized metrics and executive narratives.
Productivity/efficiency valuation: Designed enterprise framework quantifying ~$61M projected value (BioPharma + Oncology); aligned metrics to create a single benefits narrative; earlier DS&AI framework evidenced $816M+ value (creation, avoidance, savings).
Strategic resourcing: Built allocation model to resolve 25 FTE overage; aligned capacity to priority pipeline; secured 10 FTE/$1.5M uplift for CPSS; enabled reallocation of EB&SI ($14.6M, 86 FTEs).
Controls and close: Strengthened accrual governance by implementing new oversight protocols.
Operating model/reorg: Delivered ODSAI reorg cost center/department updates; ensured SAP/ASO readiness ahead of MEC/MTP; evaluated early careers cost transfers to improve planning fidelity.
Executive storytelling: Produced concise, data-driven narratives for Finance/R&D LTs, enhancing meeting-to-decision ratio and portfolio visibility.
Global Senior Finance Manager
ASTRAZENECA
Gaithersburg, USA
01.2016 - 01.2020
Project CFO for ~30 molecules (>$5B value); built valuations and business cases supporting $50M+ initiatives, grants ($107M and $50M+), and a $349M Ph3 investment (Nirsevimab).
Directed post-deal management (12+ contracts); forecasted milestones/royalties; managed alliances and cost-sharing; business partner for Microbial Sciences ($20M Opex).
Promoted to Controller and finance project lead overseeing seven teams across Roche’s Global Late Stage Product Development division.
Unlocked over $5 billion in risk-adjusted value through development of 20 investment proposals for Genentech leadership.
Secured over $500,000 in approved funding by demonstrating drug value proposition and associated risks.
Ensured fulfillment of contractual obligations with co-development partners and implemented cost-sharing arrangements.
Finance Manager
GENENTECH / THE ROCHE GROUP
South San Francisco, USA
01.2013 - 01.2015
Provided financial oversight for Genentech’s HER2 Family franchise, encompassing Herceptin, Perjeta, and Kadcyla brands worth $190M.
Held full P&L authority, estimating sales, costs, insurance reserves, and discounts to assess drug profitability.
BPA Manager – Management, Reporting & Planning
NOVARTIS DIAGNOSTICS
Emeryville, USA
01.2011 - 01.2013
Owned $180M P&L projections; developed pricing/business case model, enhancing costing accuracy by 10% and reducing prep time by 60%; supported $21M G&A planning.
Finance Manager
UNITED BEHAVIORAL HEALTH
San Francisco, USA
01.2009 - 01.2011
Analyzed financial results and performance metrics to identify trends and variances for strategic decision-making.
Managed team of three to develop financial models and forecasts, enhancing accuracy in financial planning.
Sr. Financial Analyst
UNITED BEHAVIORAL HEALTH
San Francisco, USA
01.2007 - 01.2009
Improved gross margin forecast accuracy from 1.5% to 4% through rate/volume, terminations, and pipeline analytics; led and coached a team of three.
Education
Master of Business Administration - International Business
THE GEORGE WASHINGTON UNIVERSITY
Washington, DC
Bachelor of Arts - International Affairs & Political Science
Title: SENIOR GLOBAL FINANCE PARTNER | DIRECTOR – FINANCE & ANALYTICS
Selected Impact Highlights
AI investment stewardship: Built analytics and capitalization rationale for ~$160M AI portfolio; clarified ROI/IRR by use case; staged sequencing and capex/opex policy; integrated model accuracy/throughput KPIs with financial outcomes.
Planning and decision quality: Led QBRs/MTP for ODSAI/DSAI (~$191M, 688 FTEs); improved recharge transparency; standardized driver taxonomy; achieved ±2% forecast targets; accelerated decisions via concise executive narratives.
Productivity/efficiency at scale: Designed cross-functional framework quantifying ~$61M projected value; aligned BioPharma/Oncology metrics for enterprise benefits realization; prior DS&AI framework demonstrated $816M+ value (creation, avoidance, savings).
Strategic resourcing and headcount: Eliminated 25 FTE overage; aligned capacity to pipeline; secured +10 FTE/$1.5M CPSS uplift; enabled accurate transfer of EB&SI resources ($14.6M, 86 FTEs).
Governance and close excellence: WD+1 pre-close checks; strengthened accrual governance (Cellectis); confirmed Fusion impairment; fixed asset ownership clarity (FAVE); improved R2R cycle time and reduced defects.
M&A/integration and structure: Led Fusion R&D integration readiness; mapped operating model options and finance controls; delivered ODSAI reorg updates and SAP/ASO data quality ahead of MEC/MTP.
Executive communication and alignment: Data-first narratives for Finance/R&D LTs; improved meeting-to-decision ratio and portfolio visibility; embedded KPI discipline.
Timeline
Senior Global Finance Business Partner
ASTRAZENECA
01.2020 - Current
Global Senior Finance Manager
ASTRAZENECA
01.2016 - 01.2020
Lifecycle Controller / Sr. Finance Manager
GENENTECH / THE ROCHE GROUP
01.2015 - 01.2016
Finance Manager
GENENTECH / THE ROCHE GROUP
01.2013 - 01.2015
BPA Manager – Management, Reporting & Planning
NOVARTIS DIAGNOSTICS
01.2011 - 01.2013
Finance Manager
UNITED BEHAVIORAL HEALTH
01.2009 - 01.2011
Sr. Financial Analyst
UNITED BEHAVIORAL HEALTH
01.2007 - 01.2009
Master of Business Administration - International Business
THE GEORGE WASHINGTON UNIVERSITY
Bachelor of Arts - International Affairs & Political Science
Senior Lead - Finance (Operations, Accounting, Procurement, Business Partner & Systems) at Tentang AnakSenior Lead - Finance (Operations, Accounting, Procurement, Business Partner & Systems) at Tentang Anak
<ul><li>Company Overview: Group Company of PUIG, Spain</li><li>Team Leadership & Process Excellence: Organised the transformation of the Finance & Accounts function, establishing performance-driven goals, and embedding a culture of accountability and continuous improvement. Drove operational efficiency through process redesigns, SOP implementation and optimal resource deployment, leading to measurable improvements in turnaround time and accuracy.</li><li>Strategic Partnering with CXOs: Acted as a key advisor to the CEO, CFO, and other CXOs on business planning, pricing strategies, and business model pivots to support scale-up and profitability. Contributed to investor communications with data-backed insights to enhance stakeholder confidence and secure strategic funding.</li><li>Cross-Functional & Global Stakeholder Management: Functioned as the strategic finance business partner to cross-functional heads and the PUIG global finance team, aligning local execution with global financial strategies and compliance requirements.</li><li>ERP Transformation & System Automation: Led end-to-end ERP reimplementation to address system gaps, enforce role-based controls, and automate core finance processes—resulting in enhanced data accuracy, faster reporting and improved internal controls.</li><li>Costing, Inventory & Profitability Optimization: Designed and implemented plant-level costing models to ensure accurate COGS determination. Improved inventory management across pricing, consumption tracking, and aging analysis—enabling better working capital control and cost efficiency.</li><li>Manufacturing Finance & Statutory Compliance: Supervised end-to-end accounting for manufacturing operations and ensured full statutory compliance.</li><li>Financial Reporting, MIS & Profitability Analytics: Delivered accurate and timely monthly MIS reports, including P&L, Balance Sheet and KPI dashboards with deep-dive variance analysis across stores, business verticals, and geographies. Supported board-level decision-making through insightful presentations on financial health and business performance.</li><li>Budgeting, Forecasting & Business Planning: Led the Annual Operating Plan (AOP) and rolling forecasts, ensuring alignment with strategic objectives and market dynamics. Monitored key financial metrics to enable business decisions and proactive cost management.</li><li>Statutory, Internal & Tax Audit Management: Finalized standalone and consolidated financials under Ind AS and IFRS, ensured timely group reporting and compliance with international standards. Delivered clean and timely closures of statutory, tax, and internal audits in coordination with Big 4 auditors. Strengthened audit readiness through pre-audit diagnostics and rectification of recurring control gaps.</li><li>Regulatory Compliance & Risk Management: Ensured end-to-end compliance which includes ROC, RBI, FEMA, Income Tax, GST, Transfer Pricing, DTAA, and Customs. Reviewed cross-border contracts and transactions to ensure arm’s length pricing, accurate TDS application, and proper documentation under Transfer Pricing regulations.</li><li>Commercial Negotiation & Contract Governance: Led commercial negotiations and structured deals with vendors and franchisees. Reviewed key business contracts to ensure financial viability, risk protection, and compliance with regulatory standards.</li><li>Treasury & External Commercial Borrowing (ECB): Managed fund planning and liquidity management including ECB drawdowns, bank negotiations, and interest optimization. Improved working capital cycles through proactive cash flow forecasting and receivables control.</li><li>Internal Controls & Governance Framework: Led organization-wide reviews of internal control systems, identified process gaps, and redesigned or implemented over 40 SOPs and IFCs. Established a governance structure for financial discipline, risk mitigation, and policy compliance across departments.</li></ul> at Kama Ayurveda Pvt. Ltd. & PUIG India Pvt. Ltd.<ul><li>Company Overview: Group Company of PUIG, Spain</li><li>Team Leadership & Process Excellence: Organised the transformation of the Finance & Accounts function, establishing performance-driven goals, and embedding a culture of accountability and continuous improvement. Drove operational efficiency through process redesigns, SOP implementation and optimal resource deployment, leading to measurable improvements in turnaround time and accuracy.</li><li>Strategic Partnering with CXOs: Acted as a key advisor to the CEO, CFO, and other CXOs on business planning, pricing strategies, and business model pivots to support scale-up and profitability. Contributed to investor communications with data-backed insights to enhance stakeholder confidence and secure strategic funding.</li><li>Cross-Functional & Global Stakeholder Management: Functioned as the strategic finance business partner to cross-functional heads and the PUIG global finance team, aligning local execution with global financial strategies and compliance requirements.</li><li>ERP Transformation & System Automation: Led end-to-end ERP reimplementation to address system gaps, enforce role-based controls, and automate core finance processes—resulting in enhanced data accuracy, faster reporting and improved internal controls.</li><li>Costing, Inventory & Profitability Optimization: Designed and implemented plant-level costing models to ensure accurate COGS determination. Improved inventory management across pricing, consumption tracking, and aging analysis—enabling better working capital control and cost efficiency.</li><li>Manufacturing Finance & Statutory Compliance: Supervised end-to-end accounting for manufacturing operations and ensured full statutory compliance.</li><li>Financial Reporting, MIS & Profitability Analytics: Delivered accurate and timely monthly MIS reports, including P&L, Balance Sheet and KPI dashboards with deep-dive variance analysis across stores, business verticals, and geographies. Supported board-level decision-making through insightful presentations on financial health and business performance.</li><li>Budgeting, Forecasting & Business Planning: Led the Annual Operating Plan (AOP) and rolling forecasts, ensuring alignment with strategic objectives and market dynamics. Monitored key financial metrics to enable business decisions and proactive cost management.</li><li>Statutory, Internal & Tax Audit Management: Finalized standalone and consolidated financials under Ind AS and IFRS, ensured timely group reporting and compliance with international standards. Delivered clean and timely closures of statutory, tax, and internal audits in coordination with Big 4 auditors. Strengthened audit readiness through pre-audit diagnostics and rectification of recurring control gaps.</li><li>Regulatory Compliance & Risk Management: Ensured end-to-end compliance which includes ROC, RBI, FEMA, Income Tax, GST, Transfer Pricing, DTAA, and Customs. Reviewed cross-border contracts and transactions to ensure arm’s length pricing, accurate TDS application, and proper documentation under Transfer Pricing regulations.</li><li>Commercial Negotiation & Contract Governance: Led commercial negotiations and structured deals with vendors and franchisees. Reviewed key business contracts to ensure financial viability, risk protection, and compliance with regulatory standards.</li><li>Treasury & External Commercial Borrowing (ECB): Managed fund planning and liquidity management including ECB drawdowns, bank negotiations, and interest optimization. Improved working capital cycles through proactive cash flow forecasting and receivables control.</li><li>Internal Controls & Governance Framework: Led organization-wide reviews of internal control systems, identified process gaps, and redesigned or implemented over 40 SOPs and IFCs. Established a governance structure for financial discipline, risk mitigation, and policy compliance across departments.</li></ul> at Kama Ayurveda Pvt. Ltd. & PUIG India Pvt. Ltd.